Eugene Du Toit1, Liam Browne2, Helen Irving-Rodgers1, Helen M Massa1, Nicolette Fozzard1, Michael P Jennings2, Ian R Peak3,4. 1. School of Medical Science, Griffith University, Gold Coast Campus, Southport, QLD, Australia. 2. Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, QLD, Australia. 3. School of Medical Science, Griffith University, Gold Coast Campus, Southport, QLD, Australia. i.peak@griffith.edu.au. 4. Institute for Glycomics, Griffith University, Gold Coast Campus, Southport, QLD, Australia. i.peak@griffith.edu.au.
Abstract
PURPOSE: Although there is good evidence showing that diets rich in medium chain fatty acids (MCFAs) have less marked obesogenic and diabetogenic effects than diets rich in long chain fatty acids (LCFAs), the role of the pro-inflammatory, medium chain fatty acid receptor (GPR84) in the aetiology of obesity and glucose intolerance is not well characterised. We set out to determine whether GPR84 expression influences obesity and glucose intolerance susceptibility in MCFA and LCFA rich diet fed mice. METHODS: Wild type (WT) and GPR84 knockout (KO) mice were fed a control, MCFA or LCFA diet, and body mass, heart, liver and epididymal fat mass was assessed, as well as glucose tolerance and adipocyte size. RESULTS: LCFA diets increased body mass and decreased glucose tolerance in both WT and GPR84 KO animals while MCFA diets had no effect on these parameters. There were no differences in body weight when comparing WT and GPR84 KO mice on the respective diets. Glucose tolerance was also similar in WT and GPR84 KO mice irrespective of diet. Liver mass was increased following LCFA feeding in WT but not GPR84 KO mice. Hepatic triglyceride content was increased in GPR84 KO animals fed MCFA, and myocardial triglyceride content was increased in GPR84 KO animals fed LCFA. CONCLUSIONS: GPR84 deletion had no effects on body weight or glucose tolerance in mice fed either a high MCFA or LCFA diet. GPR84 may influence lipid metabolism, as GPR84 KO mice had smaller livers and increased myocardial triglyceride accumulation when fed LCFA diets, and increased liver triglyceride accumulation in responses to increased dietary MCFAs.
PURPOSE: Although there is good evidence showing that diets rich in medium chain fatty acids (MCFAs) have less marked obesogenic and diabetogenic effects than diets rich in long chain fatty acids (LCFAs), the role of the pro-inflammatory, medium chain fatty acid receptor (GPR84) in the aetiology of obesity and glucose intolerance is not well characterised. We set out to determine whether GPR84 expression influences obesity and glucose intolerance susceptibility in MCFA and LCFA rich diet fed mice. METHODS: Wild type (WT) and GPR84 knockout (KO) mice were fed a control, MCFA or LCFA diet, and body mass, heart, liver and epididymal fat mass was assessed, as well as glucose tolerance and adipocyte size. RESULTS: LCFA diets increased body mass and decreased glucose tolerance in both WT and GPR84 KO animals while MCFA diets had no effect on these parameters. There were no differences in body weight when comparing WT and GPR84 KO mice on the respective diets. Glucose tolerance was also similar in WT and GPR84 KO mice irrespective of diet. Liver mass was increased following LCFA feeding in WT but not GPR84 KO mice. Hepatic triglyceride content was increased in GPR84 KO animals fed MCFA, and myocardial triglyceride content was increased in GPR84 KO animals fed LCFA. CONCLUSIONS:GPR84 deletion had no effects on body weight or glucose tolerance in mice fed either a high MCFA or LCFA diet. GPR84 may influence lipid metabolism, as GPR84 KO mice had smaller livers and increased myocardial triglyceride accumulation when fed LCFA diets, and increased liver triglyceride accumulation in responses to increased dietary MCFAs.
Entities:
Keywords:
Dietary study; Fatty acid receptor; Medium chain fatty acid
Authors: Brian W Parks; Tamer Sallam; Margarete Mehrabian; Nikolas Psychogios; Simon T Hui; Frode Norheim; Lawrence W Castellani; Christoph D Rau; Calvin Pan; Jennifer Phun; Zhenqi Zhou; Wen-Pin Yang; Isaac Neuhaus; Peter S Gargalovic; Todd G Kirchgessner; Mark Graham; Richard Lee; Peter Tontonoz; Robert E Gerszten; Andrea L Hevener; Aldons J Lusis Journal: Cell Metab Date: 2015-02-03 Impact factor: 27.287
Authors: Nigel Turner; Krit Hariharan; Jennifer TidAng; Georgia Frangioudakis; Susan M Beale; Lauren E Wright; Xiao Yi Zeng; Simon J Leslie; Jing-Ya Li; Edward W Kraegen; Gregory J Cooney; Ji-Ming Ye Journal: Diabetes Date: 2009-08-31 Impact factor: 9.461
Authors: Carlota Recio; Daniel Lucy; Gareth S D Purvis; Poppy Iveson; Lynda Zeboudj; Asif J Iqbal; Daniel Lin; Chris O'Callaghan; Lucy Davison; Esther Griesbach; Angela J Russell; Graham M Wynne; Lea Dib; Claudia Monaco; David R Greaves Journal: Front Immunol Date: 2018-06-20 Impact factor: 7.561
Authors: Tobias Puengel; Steve De Vos; Jana Hundertmark; Marlene Kohlhepp; Nurdan Guldiken; Philippe Pujuguet; Marielle Auberval; Florence Marsais; Kenji F Shoji; Laurent Saniere; Christian Trautwein; Tom Luedde; Pavel Strnad; Reginald Brys; Philippe Clément-Lacroix; Frank Tacke Journal: J Clin Med Date: 2020-04-16 Impact factor: 4.241
Authors: Jean-Christophe Simard; Jean-François Thibodeau; Martin Leduc; Mikael Tremblay; Alexandre Laverdure; François Sarra-Bournet; William Gagnon; Jugurtha Ouboudinar; Liette Gervais; Alexandra Felton; Sylvie Letourneau; Lilianne Geerts; Marie-Pier Cloutier; Kathy Hince; Ramon Corpuz; Alexandra Blais; Vanessa Marques Quintela; Jean-Simon Duceppe; Shaun D Abbott; Amélie Blais; Boulos Zacharie; Pierre Laurin; Steven R Laplante; Christopher R J Kennedy; Richard L Hébert; François A Leblond; Brigitte Grouix; Lyne Gagnon Journal: Sci Rep Date: 2020-07-29 Impact factor: 4.379
Authors: Derek Strassheim; Timothy Sullivan; David C Irwin; Evgenia Gerasimovskaya; Tim Lahm; Dwight J Klemm; Edward C Dempsey; Kurt R Stenmark; Vijaya Karoor Journal: Cells Date: 2021-11-29 Impact factor: 7.666